SCHEMBL7736953

SCHEMBL7736953

O=S(=O)(C(/C=C\c1ccc(F)cc1)c1ccc(Cl)cc1)C(/C=C\c1ccc(F)cc1)c1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.43
GPR183 P32249 1/20 0.40
PTGES2 Q9H7Z7 2/20 0.39
ALDH1A1 P00352 2/20 0.38
AHR P35869 1/20 0.38
HTT P42858 1/20 0.38
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
TNFRSF1A P19438 1/20 0.37
MET P08581 1/20 0.36
PTGS2 P35354 1/20 0.36
CYP1A2 P05177 1/20 0.36
HSD11B1 P28845 1/20 0.36
NFE2L2 Q16236 2/20 0.36
NOS2 P35228 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1194783 1.00 MAOB (0.43) MAOBGPR183PTGES2ALDH1A1AHR
SCHEMBL3668286 1.00 MAOB (0.43) MAOBGPR183PTGES2ALDH1A1AHR
SCHEMBL1194099 1.00 MAOB (0.43) MAOBGPR183PTGES2ALDH1A1AHR
SCHEMBL15673888 0.92 TNFRSF1A (0.42) TNFRSF1APTGS2HSD11B1NFE2L2
SCHEMBL6911087 0.92 AHR (0.44) MAOBAHRPTGS2CYP1A2NFE2L2
SCHEMBL1194120 0.92 AHR (0.44) MAOBAHRPTGS2CYP1A2NFE2L2
SCHEMBL1195539 0.85 PTGS2 (0.41) MAOBAHRPTGS2CYP1A2NFE2L2
SCHEMBL1194057 0.84 MAOB (0.50) MAOBALDH1A1AHRMAPTPTGS2
SCHEMBL1194100 0.84 MAPT (0.40) GPR183PTGES2ALDH1A1NPC1MAPT
SCHEMBL5872258 0.84 TNFRSF1A (0.37) GPR183TNFRSF1APTGS2HSD11B1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414034-B1 ANTICANCER AGENTS TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2002-07-02 US claimed
CN-102821605-B Improved stable aqueous formulations of -4-carboxystyryl-4-chlorobenzyl sulfone ONCONOVA THERAPEUTICS, INC. (US) 2015-11-25 CN disclosed
CN-104320971-A Compositions and methods for prevention and treatment of wounds ONCONOVA THERAPEUTICS INC 2015-01-28 CN disclosed